Literature DB >> 22105716

Thrombospondin-1 is a novel negative regulator of liver regeneration after partial hepatectomy through transforming growth factor-beta1 activation in mice.

Hiromitsu Hayashi1, Keiko Sakai, Hideo Baba, Takao Sakai.   

Abstract

UNLABELLED: The matricellular protein, thrombospondin-1 (TSP-1), is prominently expressed during tissue repair. TSP-1 binds to matrix components, proteases, cytokines, and growth factors and activates intracellular signals through its multiple domains. TSP-1 converts latent transforming growth factor-beta1 (TGF-β1) complexes into their biologically active form. TGF-β plays significant roles in cell-cycle regulation, modulation of differentiation, and induction of apoptosis. Although TGF-β1 is a major inhibitor of proliferation in cultured hepatocytes, the functional requirement of TGF-β1 during liver regeneration remains to be defined in vivo. We generated a TSP-1-deficient mouse model of a partial hepatectomy (PH) and explored TSP-1 induction, progression of liver regeneration, and TGF-β-mediated signaling during the repair process after hepatectomy. We show here that TSP-1-mediated TGF-β1 activation plays an important role in suppressing hepatocyte proliferation. TSP-1 expression was induced in endothelial cells (ECs) as an immediate early gene in response to PH. TSP-1 deficiency resulted in significantly reduced TGF-β/Smad signaling and accelerated hepatocyte proliferation through down-regulation of p21 protein expression. TSP-1 induced in ECs by reactive oxygen species (ROS) modulated TGF-β/Smad signaling and proliferation in hepatocytes in vitro, suggesting that the immediately and transiently produced ROS in the regenerating liver were the responsible factor for TSP-1 induction.
CONCLUSIONS: We have identified TSP-1 as an inhibitory element in regulating liver regeneration by TGF-β1 activation. Our work defines TSP-1 as a novel immediate early gene that could be a potential therapeutic target to accelerate liver regeneration.
Copyright © 2011 American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22105716      PMCID: PMC3295913          DOI: 10.1002/hep.24800

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  36 in total

1.  Thrombospondin-1 inhibits VEGF receptor-2 signaling by disrupting its association with CD47.

Authors:  Sukhbir Kaur; Gema Martin-Manso; Michael L Pendrak; Susan H Garfield; Jeff S Isenberg; David D Roberts
Journal:  J Biol Chem       Date:  2010-10-05       Impact factor: 5.157

Review 2.  Physiology of thrombospondin.

Authors:  D F Mosher
Journal:  Annu Rev Med       Date:  1990       Impact factor: 13.739

3.  Enhanced proangiogenic signaling in thrombospondin-1-deficient retinal endothelial cells.

Authors:  Yongji Wang; Shoujian Wang; Nader Sheibani
Journal:  Microvasc Res       Date:  2006-04-19       Impact factor: 3.514

4.  Regulation of cyclin-dependent kinase inhibitor p21(WAF1/Cip1/Sdi1) gene expression in hepatic regeneration.

Authors:  J H Albrecht; A H Meyer; M Y Hu
Journal:  Hepatology       Date:  1997-03       Impact factor: 17.425

5.  Mechanism of retarded liver regeneration in plasminogen activator-deficient mice: impaired activation of hepatocyte growth factor after Fas-mediated massive hepatic apoptosis.

Authors:  M Shimizu; A Hara; M Okuno; H Matsuno; K Okada; S Ueshima; O Matsuo; M Niwa; K Akita; Y Yamada; N Yoshimi; T Uematsu; S Kojima; S L Friedman; H Moriwaki; H Mori
Journal:  Hepatology       Date:  2001-03       Impact factor: 17.425

6.  Activated hepatic stellate cells overexpress p75NTR after partial hepatectomy and undergo apoptosis on nerve growth factor stimulation.

Authors:  Keiko Asai; Susumu Tamakawa; Masahiro Yamamoto; Masumi Yoshie; Yoshihiko Tokusashi; Yuji Yaginuma; Shinichi Kasai; Katsuhiro Ogawa
Journal:  Liver Int       Date:  2006-06       Impact factor: 5.828

Review 7.  Liver regeneration 4: transcriptional control of liver regeneration.

Authors:  R Taub
Journal:  FASEB J       Date:  1996-03       Impact factor: 5.191

8.  Transforming growth factor-beta (TGF-beta) isoforms in rat liver regeneration: messenger RNA expression and activation of latent TGF-beta.

Authors:  S B Jakowlew; J E Mead; D Danielpour; J Wu; A B Roberts; N Fausto
Journal:  Cell Regul       Date:  1991-07

9.  Suppression of transforming growth factor-beta-induced apoptosis through a phosphatidylinositol 3-kinase/Akt-dependent pathway.

Authors:  R H Chen; Y H Su; R L Chuang; T Y Chang
Journal:  Oncogene       Date:  1998-10-15       Impact factor: 9.867

10.  Thrombospondin-1 is a major activator of TGF-beta1 in vivo.

Authors:  S E Crawford; V Stellmach; J E Murphy-Ullrich; S M Ribeiro; J Lawler; R O Hynes; G P Boivin; N Bouck
Journal:  Cell       Date:  1998-06-26       Impact factor: 41.582

View more
  36 in total

1.  Thrombospondin-1 (TSP1)-producing B cells restore antigen (Ag)-specific immune tolerance in an allergic environment.

Authors:  Gui Yang; Xiao-Rui Geng; Zhi-Qiang Liu; Jiang-Qi Liu; Xiao-Yu Liu; Ling-Zhi Xu; Huan-Ping Zhang; Ying-Xue Sun; Zhi-Gang Liu; Ping-Chang Yang
Journal:  J Biol Chem       Date:  2015-04-03       Impact factor: 5.157

2.  Fibronectin is essential for survival but is dispensable for proliferation of hepatocytes in acute liver injury in mice.

Authors:  Kei Moriya; Keiko Sakai; Michel H Yan; Takao Sakai
Journal:  Hepatology       Date:  2012-06-05       Impact factor: 17.425

3.  Prognostic value of Ki-67 expression in conversion therapy for colorectal liver-limited metastases.

Authors:  Hiromitsu Hayashi; Toru Beppu; Yasuo Sakamoto; Yuji Miyamoto; Naomi Yokoyama; Takaaki Higashi; Hidetoshi Nitta; Daisuke Hashimoto; Akira Chikamoto; Hideo Baba
Journal:  Am J Cancer Res       Date:  2015-02-15       Impact factor: 6.166

4.  The pathogenesis of diclofenac induced immunoallergic hepatitis in a canine model of liver injury.

Authors:  Saravanakumar Selvaraj; Jung-Hwa Oh; Reinhard Spanel; Florian Länger; Hyoung-Yun Han; Eun-Hee Lee; Seokjoo Yoon; Jürgen Borlak
Journal:  Oncotarget       Date:  2017-09-23

Review 5.  Thrombospondin-1 regulation of latent TGF-β activation: A therapeutic target for fibrotic disease.

Authors:  Joanne E Murphy-Ullrich; Mark J Suto
Journal:  Matrix Biol       Date:  2017-12-27       Impact factor: 11.583

6.  Thrombospondin-1 Exacerbates Acute Liver Failure and Hepatic Encephalopathy Pathology in Mice by Activating Transforming Growth Factor β1.

Authors:  Brandi Jefferson; Malaika Ali; Stephanie Grant; Gabriel Frampton; Michaela Ploof; Sarah Andry; Sharon DeMorrow; Matthew McMillin
Journal:  Am J Pathol       Date:  2019-11-14       Impact factor: 4.307

7.  Incomplete Differentiation of Engrafted Bone Marrow Endothelial Progenitor Cells Initiates Hepatic Fibrosis in the Rat.

Authors:  Ana C Maretti-Mira; Xiangdong Wang; Lei Wang; Laurie D DeLeve
Journal:  Hepatology       Date:  2019-02-07       Impact factor: 17.425

Review 8.  Role of thrombospondin 1 in liver diseases.

Authors:  Yanzhang Li; Courtney P Turpin; Shuxia Wang
Journal:  Hepatol Res       Date:  2016-08-30       Impact factor: 4.288

9.  Dynamic Change of Total Bilirubin after Portal Vein Embolization is Predictive of Major Complications and Posthepatectomy Mortality in Patients with Hilar Cholangiocarcinoma.

Authors:  Qing Ou Yang; Sheng Zhang; Qing-Bao Cheng; Bin Li; Fei-Ling Feng; Yong Yu; Xiang-Ji Luo; Zhao-Fen Lin; Xiao-Qing Jiang
Journal:  J Gastrointest Surg       Date:  2016-01-29       Impact factor: 3.452

10.  Pregnancy prediction in single embryo transfer cycles after ICSI using QPCR: validation in oocytes from the same cohort.

Authors:  Sandra Wathlet; Tom Adriaenssens; Ingrid Segers; Greta Verheyen; Lisbet Van Landuyt; Wim Coucke; Paul Devroey; Johan Smitz
Journal:  PLoS One       Date:  2013-04-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.